Israel Englander Neogenomics Inc Transaction History

Millennium Management LLC

$192 Billion
Q4 2024

A detailed history of Israel Englander (Millennium Management LLC) transactions in Neogenomics Inc stock. As of the latest transaction made, Millennium Management LLC holds 12,000 shares of NEO stock, worth $133,200. This represents 0.0% of its overall portfolio holdings.

Number of Shares

12,000

Previous 40,275 70.2%

Holding current value

$133,200

Previous $594,000 66.84%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$13.0 - $18.43 $18 Million - $25.5 Million	1,385,514 Added 3440.13%	1,425,789 $23.5 Million
Q3 2024 Nov 14, 2024	BUY	$13.4 - $17.73 $539,685 - $714,075	40,275 New	40,275 $594,000
Q4 2023 Feb 14, 2024	BUY	$11.67 - $20.73 $595,578 - $1.06 Million	51,035 Added 39.35%	180,714 $2.92 Million
Q2 2023 Aug 14, 2023	BUY	$14.1 - $19.83 $591,918 - $832,463	41,980 Added 47.87%	129,679 $2.08 Million
Q1 2023 May 15, 2023	SELL	$9.09 - $19.45 $23.4 Million - $50 Million	-2,569,778 Reduced 96.7%	87,699 $1.53 Million
Q4 2022 Feb 14, 2023	BUY	$6.45 - $12.07 $12.8 Million - $23.9 Million	1,982,840 Added 293.91%	2,657,477 $24.6 Million
Q3 2022 Nov 14, 2022	SELL	$7.86 - $12.91 $11.7 Million - $19.2 Million	-1,489,626 Reduced 68.83%	674,637 $5.81 Million
Q2 2022 Aug 15, 2022	BUY	$7.06 - $13.97 $11.5 Million - $22.7 Million	1,626,337 Added 302.33%	2,164,263 $17.6 Million
Q1 2022 May 16, 2022	BUY	$12.15 - $35.28 $5.84 Million - $16.9 Million	480,385 Added 834.86%	537,926 $6.54 Million
Q4 2021 Feb 14, 2022	BUY	$30.49 - $48.49 $1.05 Million - $1.67 Million	34,371 Added 148.34%	57,541 $1.96 Million
Q3 2021 Nov 15, 2021	SELL	$41.66 - $52.52 $2.19 Million - $2.76 Million	-52,507 Reduced 69.38%	23,170 $1.12 Million
Q2 2021 Aug 16, 2021	SELL	$36.62 - $51.69 $6.85 Million - $9.67 Million	-187,059 Reduced 71.2%	75,677 $3.42 Million
Q1 2021 May 17, 2021	BUY	$41.56 - $59.88 $9.6 Million - $13.8 Million	230,947 Added 726.5%	262,736 $12.7 Million
Q4 2020 Feb 16, 2021	SELL	$36.08 - $56.47 $5.35 Million - $8.37 Million	-148,144 Reduced 82.33%	31,789 $1.71 Million
Q3 2020 Nov 16, 2020	BUY	$33.26 - $40.48 $5.98 Million - $7.28 Million	179,933 New	179,933 $6.64 Million
Q4 2019 Feb 14, 2020	SELL	$18.96 - $29.84 $4.2 Million - $6.61 Million	-221,668 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$19.12 - $26.24 $4.24 Million - $5.82 Million	221,668 New	221,668 $4.24 Million
Q1 2019 May 14, 2019	SELL	$12.14 - $20.46 $9.35 Million - $15.8 Million	-770,201 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$11.24 - $18.5 $8.53 Million - $14 Million	758,552 Added 6511.73%	770,201 $9.71 Million
Q3 2018 Nov 14, 2018	SELL	$12.5 - $15.38 $303,425 - $373,334	-24,274 Reduced 67.57%	11,649 $179,000
Q2 2018 Aug 14, 2018	BUY	$7.99 - $14.05 $287,024 - $504,718	35,923 New	35,923 $471,000

Others Institutions Holding NEO

# of Institutions

282

Shares Held

124M

Call Options Held

751K

Put Options Held

107K

View Full List

About NEOGENOMICS INC

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $1.4B
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

More about NEO

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account